Nanobiotix S.A. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A N/A N/A N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    (estimated) €87.58M -7.3% €14.98M -41.8% 17.1% -0.10 pp N/A N/A
    (estimated) €94.48M +232.3% €25.76M -189.7% 27.3% +1.3 pp N/A N/A
    (estimated) €28.43M -344.9% -€28.70M -57.9% -101.0% -6.9 pp N/A N/A
    -€11.61M -132.1% -€68.13M +71.6% 586.9% +7.0 pp -€18.70M +54.1% 161.1% +1.9 pp
    €36.21M +658.1% -€39.70M -30.4% -109.6% +11 pp -€12.14M -67.2% -33.5% +7.4 pp
    €4.78M +47,660.0% -€57.04M +21.4% -1,194.4% +4.7K pp -€37.01M +24.9% -774.9% +3.0K pp
    €10.00K -80.0% -€47.00M +39.8% -470,040.0% -4.0K pp -€29.64M +8.0% -296,390.0% -2.4K pp
    €50.00K -26.5% -€33.62M -34.0% -67,246.0% +76 pp -€27.43M -30.9% -54,862.0% +36 pp
    €68.00K -41.4% -€50.92M +70.3% -74,875.0% -490 pp -€39.73M +55.9% -58,419.1% -360 pp
    €116.00K -54.0% -€29.90M +14.4% -25,772.4% -150 pp -€25.48M +30.2% -21,964.7% -140 pp
    €251.97K -83.8% -€26.14M +19.5% -10,375.6% -90 pp -€19.57M +9.4% -7,766.2% -66 pp
    €1.56M +486.8% -€21.88M +28.7% -1,404.3% +50 pp -€17.88M +16.7% -1,147.8% +46 pp
    €265.54K -72.6% -€17.00M +77.9% -6,403.1% -54 pp -€15.33M +101.6% -5,771.4% -50 pp
    €967.50K +423.1% -€9.56M +17.3% -987.8% +34 pp -€7.60M +14.6% -785.7% +28 pp
    €184.94K +149.4% -€8.14M +52.8% -4,404.1% +28 pp -€6.63M +77.4% -3,587.3% +15 pp
    €74.15K -94.5% -€5.33M +1.6% -7,189.0% -68 pp -€3.74M -23.2% -5,044.1% -47 pp
    €1.36M -€5.25M -385.7% -€4.87M -358.2%

    Notifications